The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Merck
Stock and Other Ownership Interests - Merck
Pembrolizumab for patients with previously treated metastatic adenocarcinoma or squamous cell carcinoma of the esophagus: Phase 2 KEYNOTE-180 study.
 
Manish A. Shah
Research Funding - Boston Biomedical (Inst); Gilead Sciences (Inst); Lilly/ImClone (Inst); Merck (Inst); Sanofi/Regeneron (Inst)
 
Takashi Kojima
Honoraria - Oncolys BioPharma
Patents, Royalties, Other Intellectual Property - Astellas Amgen BioPharama (Inst); MSD (Inst); Oncolys BioPharma (Inst); Ono Pharmaceutical (Inst); Shionogi (Inst)
 
Peter C. Enzinger
Consulting or Advisory Role - Astellas Pharma; Five Prime Therapeutics; Merck; Taiho Pharmaceutical
 
Daniel Hochhauser
Stock and Other Ownership Interests - Novartis; Roche
Research Funding - Merck Serono
Travel, Accommodations, Expenses - Celgene
 
Judith Raimbourg
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Ipsen
 
Antoine Hollebecque
Honoraria - Merck Serono
Consulting or Advisory Role - Amgen
Travel, Accommodations, Expenses - Amgen; SERVIER
 
Florian Lordick
Honoraria - AstraZeneca; BioNTech; Bristol-Myers Squibb; Elsevier; Excerpta Medica; Lilly; Medscape; Merck Sharp & Dohme
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Sung-Bae Kim
No Relationships to Disclose
 
Masahiro Tajika
Speakers' Bureau - Ajinomoto
Research Funding - Ajinomoto (Inst)
 
Heung Tae Kim
No Relationships to Disclose
 
Albert Craig Lockhart
No Relationships to Disclose
 
Hendrik-Tobias Arkenau
No Relationships to Disclose
 
Farid El Hajbi
No Relationships to Disclose
 
Mukul Gupta
No Relationships to Disclose
 
Per Pfeiffer
No Relationships to Disclose
 
Qi Liu
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Jared Lunceford
Employment - Merck
Stock and Other Ownership Interests - Merck
 
S. Peter Kang
No Relationships to Disclose
 
Pooja Bhagia
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Ken Kato
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - MSD Oncology; Ono Pharmaceutical; Shionogi